Highlights:

• BioDuro-Sundia’s large molecule bioanalysis DMPK/ADME platform provides representative research services to a variety of molecular modalities including mAbs, ADC, oligonucleotides, large or small molecule biomarkers or metabolites, proteins and peptides.

• Within large molecule bioanalysis, therapeutic drugs, metabolites and biomarkers span a variety of large and small molecular layouts. Quantification of large molecule as well as small molecule analytes could be both critical and essential for specific drug early discovery.

• We have large molecular bioanalytical equipments of LC-MS/MS, Meso Scale Discovery (MSD) electrochemiluminescence immunoassay platform, Gyrolab automated immunoassay, microplate reader, Polymerase Chain Reaction (PCR) and sample processing instruments. BioDuro-Sundia aims to provide solid researches and better services to clients for early discovery and preclinical development of medicines as well as therapeutics.